| 000 | 01049 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515083126.0 | ||
| 264 | 0 | _c20071218 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a1369-7056 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFilson, Sarah | |
| 245 | 0 | 0 |
_aAmerican Diabetes Association - 67th scientific sessions. _h[electronic resource] |
| 260 |
_bIDrugs : the investigational drugs journal _cSep 2007 |
||
| 300 |
_a600-2 p. _bdigital |
||
| 500 | _aPublication Type: Congress | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Complications _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aRosiglitazone |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 2 _xmetabolism |
| 650 | 0 | 4 | _aSodium-Glucose Transporter 2 Inhibitors |
| 650 | 0 | 4 |
_aThiazolidinediones _xtherapeutic use |
| 773 | 0 |
_tIDrugs : the investigational drugs journal _gvol. 10 _gno. 9 _gp. 600-2 |
|
| 999 |
_c17315680 _d17315680 |
||